《新股消息》健倍苗苗(02161.HK)明日起招股入场费2,424.18元_老虎社区_美港股上老虎

《新股消息》健倍苗苗(02161.HK)明日起招股入场费2,424.18元

AAFN2021-01-25

由雅各臣分拆的从事品牌医疗保健公司健倍苗苗(02161.HK)公布招股详情，计划发售4,468.6万股股份，招股价为1.2元，每手2,000股，入场费为2,424.18元。由明日(26日)至本周五(29日)中午公开招股，预计於2月5日上市。中国银河国际证券(香港)为独家保荐人。公司预计所得款项净额估计约为1,060万元，当中47.2%将用於为品牌中药的组合开发及品牌管理提供资金；43.4%将用於作为发展第三方品牌产品组合增长策略的一部分，为从第三方品牌拥有人获得更多分销权的付款提供资金；9.4%为补充营运资金及用於一般企业用途。(sw/a)~阿思达克财经新闻网址: www.aastocks.com

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

王方文
·2021-01-26
说说你对这篇新闻的看法...
回复
点赞
举报
收起
- 社区成长助手:
  终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引
  2021-01-26
  回复
  举报

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2106443524?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","is_english":false,"pubTime":"2021-01-25 17:13","share_image_url":"https://static.laohu8.com/51f6b9126f36f92bbf92982596066e5a","id":"2106443524","market":"us","top_or_hot":-1,"title":"《新股消息》健倍苗苗(02161.HK)明日起招股 入场费2,424.18元","media":"AAFN","content":"<html><body><p>由雅各臣  分拆的从事品牌医疗保健公司健倍苗苗(02161.HK)公布招股详情，计划发售4,468.6万股股份，招股价为1.2元，每手2,000股，入场费为2,424.18元。由明日(26日)至本周五(29日)中午公开招股，预计於2月5日上市。<a href=\"https://laohu8.com/S/601881\">中国银河</a>国际证券(香港)为独家保荐人。公司预计所得款项净额估计约为1,060万元，当中47.2%将用於为品牌中药的组合开发及品牌管理提供资金；43.4%将用於作为发展第三方品牌产品组合增长策略的一部分，为从第三方品牌拥有人获得更多分销权的付款提供资金；9.4%为补充营运资金及用於一般企业用途。(sw/a)~阿思达克财经新闻网址: www.aastocks.com\t\t\t\t\t\t\t\t\t </p></body></html>","source":"aastocks","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>《新股消息》健倍苗苗(02161.HK)明日起招股 入场费2,424.18元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n《新股消息》健倍苗苗(02161.HK)明日起招股 入场费2,424.18元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-01-25 17:13 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1071608&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0><strong>AAFN</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>由雅各臣  分拆的从事品牌医疗保健公司健倍苗苗(02161.HK)公布招股详情，计划发售4,468.6万股股份，招股价为1.2元，每手2,000股，入场费为2,424.18元。由明日(26日)至本周五(29日)中午公开招股，预计於2月5日上市。中国银河国际证券(香港)为独家保荐人。公司预计所得款项净额估计约为1,060万元，当中47.2%将用於为品牌中药的组合开发及品牌管理提供资金；43.4%将用...</p>\n\n<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1071608&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02633","symbol_name":"雅各臣科研制药","start_time":0,"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1071608&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","article_id":"2106443524","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2106443524","pubTimestamp":1611566017,"columns":[{"name":"新股","id":7,"label_key":null}],"sourceInfo":{"source_id":"aastocks","name":"阿思达克财经"},"weMediaInfo":null,"summary":"由雅各臣  分拆的从事品牌医疗保健公司健倍苗苗公布招股详情，计划发售4,468.6万股股份，招股价为1.2元，每手2,000股，入场费为2,424.18元。由明日至本周五中午公开招股，预计於2月5日上市。公司预计所得款项净额估计约为1,060万元，当中47.2%将用於为品牌中药的组合开发及品牌管理提供资金；43.4%将用於作为发展第三方品牌产品组合增长策略的一部分，为从第三方品牌拥有人获得更多分销权的付款提供资金；9.4%为补充营运资金及用於一般企业用途。","collect":0,"end_time":0,"defaultTopTitle":"aastocks.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02633":"雅各臣科研制药","02161":"健倍苗苗"},"translate_title":"[News of New Shares] Jianbei Miaomiao (02161. HK) will have an entrance fee of 2,424.18 yuan from tomorrow.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02161":0.6,"02633":0.9},"content_text":"由雅各臣  分拆的从事品牌医疗保健公司健倍苗苗(02161.HK)公布招股详情，计划发售4,468.6万股股份，招股价为1.2元，每手2,000股，入场费为2,424.18元。由明日(26日)至本周五(29日)中午公开招股，预计於2月5日上市。中国银河国际证券(香港)为独家保荐人。公司预计所得款项净额估计约为1,060万元，当中47.2%将用於为品牌中药的组合开发及品牌管理提供资金；43.4%将用於作为发展第三方品牌产品组合增长策略的一部分，为从第三方品牌拥有人获得更多分销权的付款提供资金；9.4%为补充营运资金及用於一般企业用途。(sw/a)~阿思达克财经新闻网址: www.aastocks.com","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[{"id":319719469,"gmtCreate":1611621714151,"gmtModify":1703751655693,"author":{"id":"3572777412837300","authorId":"3572777412837300","name":"王方文","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3572777412837300","authorIdStr":"3572777412837300"},"htmlText":"说说你对这篇新闻的看法...","listText":"说说你对这篇新闻的看法...","text":"说说你对这篇新闻的看法...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/319719469","repostId":2106443524,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3388712,"gmtCreate":1611627076976,"gmtModify":1611627076976,"authorId":3527667803686145,"author":{"id":3527667803686145,"idStr":"3527667803686145","authorId":3527667803686145,"name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":319719469,"type":1,"supId":0,"prevId":0,"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看<a href=\"https://laohu8.com/TW/934879903\">老虎社区创作指引</a>","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看<a href=\"https://laohu8.com/TW/934879903\">老虎社区创作指引</a>","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看<a href=\"https://laohu8.com/TW/934879903\">老虎社区创作指引</a>"}],"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}